Migraines and Serotonin Agonists

Links shared publicly online about this topic

Migraine - Migraine Medications: Triptans, Antidepressants, and Serotonin Syndrome - Again.

healthcentral.com — “A Migraine and medication question just came in for our Ask the Clinician column. There is so much confusion about this that it's become necessary to address...View full resource at healthcentral.com

  • View Related
  • Share

Most Recently Shared on July 6, 2010 at 6:59 pm By:

TRobert Teri Robert Patient Expert

Migraine - Migraine Medications: Triptans, Antidepressants, and Serotonin Syndrome - Again.: http://bit.ly/cxHhO3 via @addthis

2 years ago...

Neurology Medical News about Migraine Disorders 5-HT1F Receptor Agonists

mdlinx.com — “5-HT1F Receptor Agonists: A New Treatment Option for Migraine Attacks?View full resource at mdlinx.com

  • View Related
  • Share

Most Recently Shared on May 4, 2010 at 7:03 pm By:

MDLinx Sandeep Pulim MD Doctor, Health Communicator, and Physician

5-HT1F Receptor Agonists: A New Treatment Option for Migraine Attacks?: Neurotherapeutics http://bit.ly/cCBPff #neurology #mdlinx

2 years ago...

Migraine Headaches: Ways to Deal With the Pain

familydoctor.org — “Information about migraine headaches from the American Academy of Family Physicians.View full resource at familydoctor.org

  • View Related
  • Share

Most Recently Shared on June 30, 2009 at 11:23 pm By:

Medical News: AAN: Glutamate Receptor Inhibitors May Help Migraine - in Meeting Coverage, AAN from MedPage Today

medpagetoday.com — “SEATTLE -- Inhibition of glutamate receptors may play a role in migraine treatment, researchers here said.View full resource at medpagetoday.com

  • View Related
  • Share

Most Recently Shared on April 30, 2009 at 4:35 pm By:

medpagetoday MedPage Today Health News

AAN: Glutamate Receptor Inhibitors May Help Migraine http://medpagetoday.com/13992

3 years ago...

Sumavel DosePro available for acute migraine and cluster headache - MPR

empr.com — “Zogenix and Astellas have made available Sumavel DosePro (sumatriptan injection), a selective 5-HT1B/1D receptor agonist in a needle-free delivery system, for the acute treatment of migraine attacks, with or without aura, and the acute treatment of cluster headache episodes.View full resource at empr.com

  • View Related
  • Share

Most Recently Shared on January 13, 2010 at 4:23 pm By:

eMPR MPR Medical Publisher

MPR News: Sumavel DosePro available for acute migraine and cluster headache: Zogenix and Astellas have made availa... http://bit.ly/7bcgpL

2 years ago...

Alsuma Auto-Injector available for acute migraine and cluster headache - MPR

empr.com — “Meridian Medical has made available Alsuma (sumatriptan injection auto-injector), a selective 5-HT1B/1D receptor agonist, for the acute treatment of migraine attacks, with or without aura, and the acute treatment of cluster headache episodes.View full resource at empr.com

  • View Related
  • Share

Most Recently Shared on December 7, 2010 at 5:26 pm By:

eMPR MPR Medical Publisher

MPR News: Alsuma Auto-Injector available for acute migraine and cluster headache: Meridian Medical has made avai... http://bit.ly/eTM00A

1 year ago...

CoLucid's lasmiditan NAAMA effective in treatment of acute migraine attacks

news-medical.net — “CoLucid Pharmaceuticals, Inc.,, an innovative biotechnology company focusing on therapies for central nervous system disorders, today announced that its investigational first-in-class Neurally Acting Anti-Migraine Agent (NAAMA), lasmiditan (also known as COL-144), a selective 5-HT1F receptor agonist, was effective when given orally to treat acute migraine attacks, as documented in a Phase IIb study.View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on June 10, 2010 at 7:50 am By:

Stroke_News News-Medical.Net Health News

Stroke News: CoLucid's lasmiditan NAAMA effective in treatment of acute migraine attacks: CoLucid Pharmaceutical... http://twurl.nl/e17gwo

2 years ago...

Is atopic disease a risk factor for attention-defi... [Allergy. 2010] - PubMed result

ncbi.nlm.nih.gov — “PubMed is a service of the U.S. National Library of Medicine that includes over 19 million citations from MEDLINE and other life science journals for biomedical articles back to the 1950s. PubMed includes links to full text articles and other related resources.View full resource at ncbi.nlm.nih.gov

  • View Related
  • Share

Most Recently Shared on August 25, 2010 at 8:52 pm By:

Sumavel DosePro approved for acute migraine and cluster headache - MPR

empr.com — “The FDA has approved Sumavel DosePro (sumatriptan injection, from Zogenix and Astellas), a selective 5-HT1B/1D receptor agonist in a needle-free delivery system, for the acute treatment of migraine attacks, with or without aura, and the acute treatment of cluster headache episodes.View full resource at empr.com

  • View Related
  • Share

Most Recently Shared on July 16, 2009 at 3:42 pm By:

eMPR MPR Medical Publisher

MPR News: Sumavel DosePro approved for acute migraine and cluster headache: The FDA has approved Sumave.. http://bit.ly/19OwVS

3 years ago...

Comorbid Migraine Does Not Affect Efficacy of Milnacipran in Management of Fibromyalgia - MPR

empr.com — “In patients with fibromyalgia, milnacipran efficacy is not affected by the presence of comorbid migraine headache, examination of pooled data from three randomized, double-blind, placebo-controlled clinical trials of the dual serotonin- and norepinephrine-reuptake inhibitor has found. The study was presented at The American Pain Society's 29th Annual Scientific Meeting.View full resource at empr.com

  • View Related
  • Share

Most Recently Shared on May 7, 2010 at 3:43 pm By:

eMPR MPR Medical Publisher

APS: Comorbid Migraine Does Not Affect Efficacy of Milnacipran in Management of Fibromyalgia: In patients with fib... http://bit.ly/ag9VHB

2 years ago...

BLOSSOM study

theheart.org — “Among overweight patients, including those with preexisting echocardiographic valvulopathy, the average weight loss was approximately 5 kg with lorcaserin. Importantly, there were no concerns raised about new or worsening cardiac valve problems with the 5HT2C-receptor agonist.View full resource at theheart.org

  • View Related
  • Share

Most Recently Shared on October 27, 2009 at 8:46 pm By:

theheartorg Shelley Wood Cardiology

heartwire: Lorcaserin passes weight-loss and valvular hurdles in BLOSSOM study http://bit.ly/4ttPu7

3 years ago...

Toxicity, Clonidine: eMedicine Emergency Medicine

emedicine.medscape.com — “Overview: Clonidine is a central alpha-agonist that is used as an antihypertensive agent. Other reported clinical uses include treatment of opiate and alcohol withdrawal and control of atrial fibrillation with a rapid ventricular rate. It is also ...View full resource at emedicine.medscape.com

  • View Related
  • Share

Most Recently Shared on April 30, 2010 at 10:35 pm By:

Health_SS Susan S Health Advocate

The anti-hypertensive drug clonidine, when misused, can cause serious health issues almost immediately. Learn more. http://bit.ly/c12gI3

2 years ago...

Clinical Data, Inc. Announces Approval Of Generic Name Vilazodone, First In A New Class Of Experimental Treatments For Depression

medicalnewstoday.com — “Clinical Data, Inc. (NASDAQ: CLDA) announced today that the United States Adopted Name Council (USAN) has approved the generic name vilazodone hydrochloride.View full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on June 22, 2009 at 4:01 pm By:

psychiatry_md psychiatryrounds Psychiatry and Support

Clinical Data, Inc. Announces Approval Of Generic Name Vilazodone, First In A New Class Of Experimental Treatmen.. http://tinyurl.com/laprw7

3 years ago...

Drug-induced fibrotic valvular heart disease : The Lancet

thelancet.com — “Drug-induced fibrotic valvular heart disease. By - Sanjeev Bhattacharyya MRCP, Prof Anthony H Schapira FMedSci, Dimitri P Mikhailidis FRCP, Dr Joseph Davar MRCPView full resource at thelancet.com

  • View Related
  • Share

Most Recently Shared on August 17, 2009 at 5:01 pm By:

mauron M Auron MD Doctor, Pediatrician, Internist, and Physician

Ectasy and MDMA linked to fibrotic valvular heart disease - http://bit.ly/3W5JLh

3 years ago...

Lorcaserin and obesity

theheart.org — “In addition to the weight loss with the selective serotonin 2C receptor agonist, an assessment of adverse events at one and two years did not show any difference in the rates of cardiac valvulopathy, a problem that was observed with less selective obesity agents, report investigators.View full resource at theheart.org

  • View Related
  • Share

Most Recently Shared on July 14, 2010 at 9:19 pm By:

theheartorg Shelley Wood Cardiology

Significant weight loss in obese and overweight patients treated with lorcaserin: In addition to the weight loss w... http://bit.ly/aDVABp

2 years ago...

The Top 3 resources shared on this topic. More resources.

Key stats and trends about this topic

Related Health Centers

Featuring the top 3 experts for this topic

  • TRobert

    Teri Robert

    Writer/patient advocate, Migraines/headaches. Author Living Well with Migraine Disease & Headaches, Work for MyMigraineConnection.com, HealthCentral.com

    View Profile

  • MDLinx

    Sandeep Pulim MD

    Over 2K medical journal articles & health news summarized and delivered FREE to 35 specialties daily. Oncology, Rheumatology, Cardiology, Neurology, Psychiatry

    View Profile

  • PainMedCs

    Pain Med Consultants

    Pain Medicine Consultants specializes in pain relief, with offices in Tampa and Sarasota.

    View Profile

Advertisement

Share via Email

Share this WisdomCard with others by embedding on your site or blog.

300x260

425x300

560x390